Sales & Marketing

Executives should embrace design to discover new markets and find new ways to server customers.

How a small competitor benefited from the use of interactive marketing.

Illegal online pharmacies are on the rise, brandjacking dozens of big name pharmaceuticals and netting almost $11 billion in sales this year alone. With consumers on the hunt for affordable meds, the trend is only going to get worse.

Big Pharma navigates a regulatory minefield to reach social media consumers. It's anything but 'business as usual.'

With the emergence of user-generated content, marketers have to keep up on the buzz around their brands and categories on the Web.

Close the loop between the pros and the consumers by integrating patient-physician communications into pharma brand planning.

The prescription for better pharma marketing: Gain understanding of your physician-customers by leveraging key analytical insights.

Initial survey and results suggest that health games and virtual worlds bear the potential to be "game changers" by improving education, provoking greater engagement, and engendering positive behavior to enhance health and wellness.

In an era of blurred channels and information clutter, it is critical for brand managers to develop a unified strategy that bridges the gaps between audiences.

The drug giant, last week, started tweeting about corporate initiatives, job openings, and news. Is Pfizer just jumping on the bandwagon, or is Twitter part of the company's social media strategy? Pharm Exec talks to Pfizer to find out more.

Dani Friedland examines what Johnson & Johnson and other pharmaceutical companies are doing to succeed online.

Agency Insider Mark Chattaway infiltrates the world of online social media. His consensus: Advertising on social networks is iffy at best

What community organizing can teach pharma marketers about building a brand.

Thought leaders are a critical component of a pharmaceutical company?s professional marketing and medical strategies. But companies face a real challenge in creating, maintaining, and leveraging those relationships while safely navigating logistical issues and regulatory waters.

In an effort to learn as more about epilepsy sufferers, UCB will implement a social network that allows patients to communicate about their disease state and treatments. Think of it as one giant, online clinical trial.

What do you do when you are introducing a new drug in an already crowded category? Wyeth queried depression sufferers to find out what they want to see in a drug ad before launching its new DTC campaign for Pristiq.

The key to managing the pharma sales force is to know when the customer wants good customer service, and when the customer needs good self-service.

With staggering year-over-year growth, biosimilars are "the future of medicine." Marketers must position their companies for the inevitable changes.

A multi-phase implementation strategy can debunk the myth that social media won't work for pharma.

Cancer patients worry not only about their disease, but also the side effects of the drugs they take to treat it. Now the Centers for Disease Control and Prevention and biologics firm Amgen are partnering on a multi-prong program to get patients to pay attention to another, related, danger: chemo-related infections.

Two Democratic Congressman have brewed up new legislation to target pharma erectile dysfunction ads rather than going after advertisements with sexually suggestive material in general. Industry experts don't think they have a chance, but the bill could still be a pain for fans of Viva Viagra.

New prescriptions for antiviral treatments get huge boost due to H1N1 epidemic. Numbers exceed those seen during this year's influenza season, and the numbers are climbing.

Despite the downside in ad spend, an upside remains in the digital space that's wide open for exploration.

In an era of shrinking marketing budgets, increase ROI with behavioral science-based marketing.

Pharma marketers face a crisis in digital media. But there's a way to turn it around.

Marketers must stress that maintaining good health behaviors is one of the best things people can do to survive a down market.

Ortho-McNeil is reaching out to the adult ADHD segment through the popular social networking site. The plan is to grow followers through education and unbranded information. Pharm Exec takes a look at the new site.

After last week’s flurry of FDA warning letters directed at companies marketing through search ads, industry is left wondering what can be done be done to target patients online?

Rather than ignore its aging mini-stroke medication Aggrenox, BI has shifted marketing to education by launching an unbranded site dedicated to informing sufferers about transient ischemic attacks, better known as TIA.

There's a temptation for companies to view predictive markets as a silver bullet. Can crowds actually do a better job than "experts," or is that viewpoint more of a fad than a foundation for accurate future forecasting?